LAD191

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAD191, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LAD191 in Adults With Hidradenitis Suppurativa [Phase 2]